1. Figure 5 Risk factor control in the intensive treatment group
of the Steno-2 trial in patients with type 2 diabetes mellitus and microalbuminuria151
Figure 5 | Risk factor control in the intensive treatment group of the Steno-2 trial in patients with type 2 diabetes mellitus and microalbuminuria151. Percentage of patients in the intensive therapy group (n = 80) who did not reach the intensive treatment goals at a mean follow-up of 7.8 years. To convert values for cholesterol to mmol/l, multiply by To convert values for triglycerides to mmol/l, multiply by BP, blood pressure; HbA1c, haemoglobin A1c.
Muskiet, M. H. A. et al. (2017) GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
Nat. Rev. Nephrol. doi: /nrneph